MedPath

Capnography During Upper GI Endoscopy

Phase 3
Completed
Conditions
Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for Interventional Upper GI Endoscopy
Registration Number
NCT01242345
Lead Sponsor
Ruhr University of Bochum
Brief Summary

In this randomized controlled trial the utility of capnography and IPI gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Age>=18
  • Scheduled for interventional upper GI endoscopy with midazolam and propofol sedation
Exclusion Criteria
  • No informed consent
  • ASA IV or V
  • Emergency endoscopy
  • Preexisting hypotension, bradycardia or hypoxemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HypoxemiaFrom the start to the end of endoscopy, i.e. from 0 h to approximately 2 h
Secondary Outcome Measures
NameTimeMethod
Further complicationsFrom the start to the end of endoscopy, i.e. from 0 h to approximately 2 h

Trial Locations

Locations (3)

Ruhr Universität Bochum

🇩🇪

Bochum, Germany

Technische Universität München

🇩🇪

München, Germany

Deutsche Klinik für Diagnostik

🇩🇪

Wiesbaden, Germany

Ruhr Universität Bochum
🇩🇪Bochum, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.